The huge demand for effective new weight management drugs has billionaire investors feeling bullish about this stock.

The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence ...

Buying $1000 In VKTX: If an investor had bought $1000 of VKTX stock 5 years ago, it would be worth $7,460.69 today based on a ...

Shares of Viking Therapeutics VKTX have more than tripled in market value in the past year. The upside was triggered by ...

Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $55.39 which represents a decrease of $-2.71 or -4.66% from the prior close of $58.1. The stock opened at $57.72 and touched a low ...

Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” second quarter 2024 investor ...

We recently compiled a list of the Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks. In this article, we ...

The new drugs this company is developing could be worth a lot more than the present market value of its stock.

Viking Therapeutics' financial stability supports its ongoing and future clinical trials, making it a viable long-term ...

Viking Therapeutics is advancing VK2735 directly to Phase 3 trials. It faces competition from NVO and LLY and has solid cash ...

The much-feted biotech Viking Therapeutics (NASDAQ: VKTX) is aiming for Novo Nordisk's (NYSE: NVO) cash cow, the market for weight loss drugs. If its ambitions are fulfilled, it has a shot at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...